Weiqing Tang

3.8k total citations · 1 hit paper
64 papers, 2.6k citations indexed

About

Weiqing Tang is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Weiqing Tang has authored 64 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Surgery and 12 papers in Oncology. Recurrent topics in Weiqing Tang's work include Cholesterol and Lipid Metabolism (12 papers), Drug Transport and Resistance Mechanisms (10 papers) and MicroRNA in disease regulation (8 papers). Weiqing Tang is often cited by papers focused on Cholesterol and Lipid Metabolism (12 papers), Drug Transport and Resistance Mechanisms (10 papers) and MicroRNA in disease regulation (8 papers). Weiqing Tang collaborates with scholars based in China, United States and Sweden. Weiqing Tang's co-authors include Xiuqing Huang, Jian Li, Tao Shen, Lin Dou, Mingjing Yan, Jun Guo, Liqing Yu, Yinyan Ma, Joanna P. Davies and Yiannis A. Ioannou and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Weiqing Tang

61 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments

2022 808 citations Jun Guo, Xiuqing Huang et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiqing Tang China	24	1.1k	647	472	405	365	64	2.6k
Yi‐Cheng Chang Taiwan	31	986 0.9×	495 0.8×	436 0.9×	504 1.2×	251 0.7×	128	3.1k
Yan Lü China	34	1.3k 1.2×	414 0.6×	632 1.3×	920 2.3×	336 0.9×	116	3.5k
Weixing Wang China	32	1.4k 1.2×	816 1.3×	282 0.6×	389 1.0×	646 1.8×	236	4.1k
Young‐Man Cho Japan	27	1.0k 0.9×	409 0.6×	298 0.6×	343 0.8×	210 0.6×	108	3.0k
Shuichi Tsuruoka Japan	32	1.3k 1.1×	474 0.7×	541 1.1×	163 0.4×	397 1.1×	194	3.7k
Yuanyuan Zhang China	37	2.0k 1.8×	332 0.5×	428 0.9×	692 1.7×	399 1.1×	209	4.7k
Yunlong Zhang China	32	943 0.8×	382 0.6×	447 0.9×	234 0.6×	144 0.4×	123	3.2k
Atsushi Kuno Japan	37	1.8k 1.6×	492 0.8×	747 1.6×	639 1.6×	253 0.7×	126	4.1k
Wen‐Ying Chen Taiwan	36	1.4k 1.3×	294 0.5×	385 0.8×	563 1.4×	270 0.7×	206	4.5k
Jiarui Wu China	30	1.8k 1.6×	430 0.7×	473 1.0×	479 1.2×	380 1.0×	247	4.3k

Countries citing papers authored by Weiqing Tang

Since Specialization

Citations

This map shows the geographic impact of Weiqing Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqing Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqing Tang more than expected).

Fields of papers citing papers by Weiqing Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqing Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqing Tang. The network helps show where Weiqing Tang may publish in the future.

Co-authorship network of co-authors of Weiqing Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqing Tang. A scholar is included among the top collaborators of Weiqing Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqing Tang. Weiqing Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Kun, Jiannan Wang, Bing Liu, et al.. (2023). Apigenin alleviates oxidative stress-induced myocardial injury by regulating SIRT1 signaling pathway. European Journal of Pharmacology. 944. 175584–175584. 32 indexed citations

Zhang, Xiaoyi, Xiyue Zhang, Tao Shen, et al.. (2023). Phosphoenolpyruvate induces endothelial dysfunction and cell senescence through stimulation of metabolic reprogramming. Journal of Bioenergetics and Biomembranes. 55(2). 103–114. 6 indexed citations

Yan, Mingjing, Yuan Cao, Que Wang, et al.. (2022). miR‐488‐3p Protects Cardiomyocytes against Doxorubicin‐Induced Cardiotoxicity by Inhibiting CyclinG1. Oxidative Medicine and Cellular Longevity. 2022(1). 5184135–5184135. 12 indexed citations

Liu, Wantao, et al.. (2022). EAIS: Energy-aware adaptive scheduling for CNN inference on high-performance GPUs. Future Generation Computer Systems. 130. 253–268. 19 indexed citations

Guo, Jun, Xiuqing Huang, Lin Dou, et al.. (2022). Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduction and Targeted Therapy. 7(1). 391–391. 808 indexed citations breakdown →

Xu, Kun, Shenghui Sun, Mingjing Yan, et al.. (2022). DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression. Frontiers in Oncology. 12. 943032–943032. 38 indexed citations

Zhang, Xiyue, Tao Shen, Hongxia Li, et al.. (2022). DDX17 protects hepatocytes against oleic acid/palmitic acid-induced lipid accumulation. Biochemical and Biophysical Research Communications. 612. 169–175. 5 indexed citations

Mu, Hongna, Qi Zhou, Ruiyue Yang, et al.. (2021). Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice. Food Research International. 143. 110240–110240. 80 indexed citations

Liu, Wantao, et al.. (2020). Evaluating and analyzing the energy efficiency of CNN inference on high‐performance GPU. Concurrency and Computation Practice and Experience. 33(6). 20 indexed citations

10.

Yu, Xiaoxue, Yang Ruan, Tao Shen, et al.. (2020). Dexrazoxane Protects Cardiomyocyte from Doxorubicin‐Induced Apoptosis by Modulating miR‐17‐5p. BioMed Research International. 2020(1). 5107193–5107193. 43 indexed citations

11.

Yu, Xiaoxue, Yang Ruan, Xiuqing Huang, et al.. (2019). Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes. Biochemical and Biophysical Research Communications. 523(1). 140–146. 75 indexed citations

12.

Guo, Jun, Weiwei Fang, Libo Sun, et al.. (2018). Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation. Nature Communications. 9(1). 612–612. 82 indexed citations

13.

Guo, Jun, Xin Lin, Xiangyu Meng, et al.. (2017). Hepatic MiR-291b-3p Mediated Glucose Metabolism by Directly Targeting p65 to Upregulate PTEN Expression. Scientific Reports. 7(1). 39899–39899. 20 indexed citations

14.

Lin, Xin, Shuyue Wang, Libo Sun, et al.. (2017). Mir-338-3p Mediates Tnf-A-Induced Hepatic Insulin Resistance by Targeting PP4r1 to Regulate PP4 Expression. Cellular Physiology and Biochemistry. 41(6). 2419–2431. 32 indexed citations

15.

Meng, Xiangyu, Jun Guo, Weiwei Fang, et al.. (2016). Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5′-Monophosphate (AMP)-activated Protein Kinase α1. Journal of Biological Chemistry. 291(20). 10625–10634. 38 indexed citations

16.

Liu, Yong‐Jin, et al.. (2013). Cylinder Detection in Large-Scale Point Cloud of Pipeline Plant. IEEE Transactions on Visualization and Computer Graphics. 19(10). 1700–1707. 82 indexed citations

17.

Tang, Weiqing, Lin Jia, Yinyan Ma, et al.. (2011). Ezetimibe restores biliary cholesterol excretion in mice expressing Niemann–Pick C1-Like 1 only in liver. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1811(9). 549–555. 28 indexed citations

18.

Jia, Lin, Yinyan Ma, Shunxing Rong, et al.. (2010). Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis. Journal of Lipid Research. 51(11). 3135–3144. 56 indexed citations

19.

Li, Zhiqiang, Tae‐Sik Park, Yán Li, et al.. (2009). Serine palmitoyltransferase (SPT) deficient mice absorb less cholesterol☆. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1791(4). 297–306. 30 indexed citations

20.

Temel, Ryan E., Weiqing Tang, Yinyan Ma, et al.. (2007). Hepatic Niemann-Pick C1–like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. Journal of Clinical Investigation. 117(7). 1968–1978. 298 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact